Gypenosides attenuate H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway. [PDF]
Ma C +6 more
europepmc +1 more source
Triglyceride-driven pathogenesis in thyroid-associated ophthalmopathy: a dual approach of clinical correlation and genetic causality. [PDF]
Cao JM, Chen HY, Zhang F, Xiong W.
europepmc +1 more source
Thyrotropin and growth promoting immunoglobulin (TGI) of FRTL-5 cells have no growth stimulating activity on human thyroid epithelial cell cultures [PDF]
Bay, V. +9 more
core
The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI. [PDF]
Yuan X, Li H, Wang F.
europepmc +1 more source
Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]
Bonny M +6 more
europepmc +1 more source
Contiguous orbital inflammation from paranasal sinus abnormalities in etiology of thyroid-associated ophthalmopathy. [PDF]
Hao XX, Tao YX, Xu X, Liu MM, Li Y.
europepmc +1 more source
Quantitative Chemical Exchange Saturation Transfer MRI for Diagnosing Thyroid-Associated Ophthalmopathy Activity: A Prospective Feasibility Study. [PDF]
Wang Y +13 more
europepmc +1 more source
Quantitative intravoxel incoherent motion diffusion-weighted imaging histogram profiling identifies diffusion biomarkers for active thyroid-associated ophthalmopathy. [PDF]
Li D, Zhang N, Wang Y, Zhu T.
europepmc +1 more source
Editorial: Thyroid eye disease. [PDF]
Kahana A +4 more
europepmc +1 more source
Clinical value of dual-energy CT parameters combined with morphological features in predicting graves' ophthalmopathy. [PDF]
Ma Z +7 more
europepmc +1 more source

